Development of a versatile lab-on-a-cartridge platform for rapid, multiplexed detection of pathogens like SARS-CoV-2 and Influenza, as well as contaminants in food. This innovative technology aims to enhance public health monitoring and ensure food safety through scalable and cost-effective diagnostics.

Sensor chip production for a molecular recognition platform in medical diagnostics in general and for SARS-CoV-2 diagnostics (both antibody and viral genetic material testing) in particular.

In the intricate realm of blood disorders, Von Willebrand Disease (VWD) emerges as a prevalent yet often misunderstood condition. With Technoclone's latest initiative, the landscape of VWD diagnostics is on the brink of transformation, promising a future of enhanced accuracy, speed, and accessibility in patient care.

Enzyre is revolutionizing personalized diagnostics with its groundbreaking chemiluminescent microfluidic platform, the EnzySystem. This innovative technology enables precise, near-patient testing of multiple coagulation markers from just a single drop of blood, transforming how bleeding disorders are managed and diagnosed.

Novus Dx’s SepTec technology, developed with the Microfluidics Innovation Hub, revolutionizes sepsis diagnostics by providing rapid and accurate pathogen detection directly from whole blood in just 15 minutes. This near-patient system combines advanced microfluidic and electrochemical technologies to improve patient outcomes through faster, more reliable sepsis diagnosis.